Ross Upton
@drrossupton.bsky.social
Founder CEO & Chief Scientific Officer, Ultromics
AI, Echocardiography, #CardioSky
University of Oxford
AI, Echocardiography, #CardioSky
University of Oxford
🧠 Can Imaging Be a Surrogate Endpoint in Amyloidosis Trials?
A recent JACC:CVI review by Dorbala et al. highlights the role of imaging biomarkers in clinical trials for amyloidosis.
www.jacc.org/doi/abs/10.1...
A recent JACC:CVI review by Dorbala et al. highlights the role of imaging biomarkers in clinical trials for amyloidosis.
www.jacc.org/doi/abs/10.1...
March 10, 2025 at 4:38 PM
🧠 Can Imaging Be a Surrogate Endpoint in Amyloidosis Trials?
A recent JACC:CVI review by Dorbala et al. highlights the role of imaging biomarkers in clinical trials for amyloidosis.
www.jacc.org/doi/abs/10.1...
A recent JACC:CVI review by Dorbala et al. highlights the role of imaging biomarkers in clinical trials for amyloidosis.
www.jacc.org/doi/abs/10.1...